logo

Arcutis Biotherapeutics Inc (ARQT) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Arcutis Biotherapeutics Inc’s current trading price is -18.64% away from its 52-week high, while its distance from the 52-week low is 611.93%. The stock’s price range during this period has varied between $1.76 and $15.40. The company, active in the Healthcare sector, saw a trading volume of around 4.91 million for the day, considerably higher average daily volume of 4.73 million observed over the last three months.

Arcutis Biotherapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $15.40 on 04/13/23, and the lowest price during the same period was recorded at $1.76 on 12/01/23.

How Financial Performance Impacts Market Capitalization

Arcutis Biotherapeutics Inc (ARQT) has experienced a quarterly rise of 237.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.44B and boasts a workforce of 296 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.95, with a change in price of +10.63. Similarly, Arcutis Biotherapeutics Inc recorded 5,157,721 in trading volume during the last 100 days, posting a change of +557.74%.

How ARQT’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ARQT stands at 2.32. Similarly, the long-term debt-to-equity ratio is also 2.31.

ARQT Stock Stochastic Average

As of today, the raw stochastic average of Arcutis Biotherapeutics Inc over the past 50 days is 98.84%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 97.45%. Additionally, the Stochastic %K and %D values for the company were 82.76% and 58.13%, respectively, over the past 20 days.

ARQT Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 287.93%.However, over the last six months, we can see a weaker performance of 182.84%. Over the last 30 days, the price of ARQT has fallen by 20.71%. And in the last five days, it has surged by 29.44%.